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A new spontaneously diabetic strain of the Sprague-
Dawley rat was established in 1997 and named
the SDT (Spontaneously Diabetic Torii) rat. In this
research, we investigated the characteristics of the
disease condition in the SDT rats. The time of on-
set of glucosuria was different between male and
female SDT rats; glucosuria appeared at approxi-
mately 20 weeks of age in male rats and at approxi-
mately 45 weeks of age in female rats. A cumulative
incidence of diabetes of 100% was noted by 40
weeks of age in male rats, while it was only 33.3%
even by 65 weeks of age in female rats. The survi-
val rate up to 65 weeks of age was 92.9% in male
rats and 97.4% in female rats. Glucose intolerance
was observed in male rats from 16 weeks of age.
The clinical characteristics of the male SDT rats
were (1) hyperglycemia and hypoinsulinemia (from
25 weeks of age); (2) long-term survival without in-
sulin treatment; (3) hypertriglyceridemia (by 35
weeks of age); however, no obesity was noted in
any of the male rats. The histopathological char-
acteristics of the male rats with diabetes mellitus
(DM) were (1) fibrosis of the pancreatic islets (by
25 weeks of age); (2) cataract (by 40 weeks of age);
(3) tractional retinal detachment with fibrous prolif-
eration (by 70 weeks of age) and (4) massive hemor-
rhaging in the anterior chamber (by 77 weeks of age).
These clinical and histopathological characteristics
of the disease in SDT rats resemble those of human
Type 2 diabetes with insulin hyposecretion. In con-
clusion, SDT rat is considered to be a potentially
useful model for studies of diabetic retinopathy
encountered in humans.
Keywords: Type 2 diabetes, non-obese, Spontaneously
Diabetic Torii strain, pancreatic fibrosis, cataract, diabetic
retinopathy
INTRODUCTION
Diabetes mellitus (DM) has become a global
health problem; the incidence of the disease
is graually increasing in all regions of the
world. [1-3] The number of people suffering
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from DM is expected to rise to 2.21 billion by
the year 2010. [4] Diabetes is not a disease of any
single organ. To clarify the complicated nature
of the disease, studies using diabetic animal
models are essential. In particular, the develop-
ment of spontaneously diabetic animal models
is very important to clarify the pathogenesis
of DM and the pattern of development of com-
plications in the human disease course. So
far, many spontaneously diabetic animal models
have been reported, including Type 1 models
such as Bio-Breeding (BB) rats,
[5 Non-Obese-
Diabetic (NOD) mice,
[6] Long-Evans-Tokushima-
Lean (LETL) rats
[7 and Komeda-Diabetes-Prone
(KDP) rats. [8 Type 2 models such as ob/ob
mice,
[91 KK mice,
[101 db/db mice,
[11] Goto-Kaki-
zaki (GK) rats,
[2] Wistar fatty rats
[13] and
Otsuka-Long-Evans-Tokushima-Fatty (OLETF)
rats [14] are also well known. These models, in
which the pattern of progression and symptoms
closely mimic those of DM in humans, play a
significant role in diabetes research, even though
any single model may be inadequate for clarify-
ing all the issues related to the disease. We
established a new inbred strain, the Sponta-
neously Diabetic Torii (SDT) rats, which survive
for a long time with hyperglycemia, even with-
out insulin therapy and may be useful particu-
larly for the research of retinopathy. They
exhibit tractional retinal detachment with fi-
brous proliferation of retinopathy similar to that
occurring in human diabetes. In the present
report, we describe the pathophysiological char-
acteristics of SDT rats.
MATERIALS AND METHODS
Establishment of the SDT Rat
In 1988, five male rats with polyuria and gluco-
suria were recognized among 305 rats from an
outbred colony of the Crj CD(SD) strain (Charles
River Japan, Inc., Kanagawa, Japan) of Sprague-
Dawley rats. Polyphagia and polydipsia were
also noted in the affected rats, which were kept
in the Research Laboratories of Torii Pharmaceu-
tical Co., Ltd., Chiba, Japan. After 20th genera-
tion of sister-brother mating, the diabetic strain
was established in 1997, and named the Sponta-
neously Diabetic Torii (SDT) rat. SDT rats were
maintained in a specific pathogen-free (SPF) facil-
ity in our laboratory, especially with regard
to the following microorganisms: Sendai virus,
Sialodacryoadenitis virus, the pneumonia virus
of mice, mouse encepalomyelitis virus, Kilham
rat virus, H-1 virus, the minute virus of mice,
Hantavirus, mouse adenovirus, Mycoplasma
pulmonis, Bacillus piliformis, CAR bacillus,
Bordetella bronchiseptica, Corynebacterium kutscheri,
Pasteurella pneumotropica, Pseudomonas aeruginosa,
Salmonella spp, Salmonella typhimurium, Strep-
tococcus pneumoniae, Dermatophytes, Giardia
muris, Spironucleus muris and Syphacia spp.
Animals
The SDT rats were raised at the Research
Laboratories of Torii Pharmaceutical Co., Ltd.
Crj "CD(SD) rats were purchased from Charles
River Japan, Inc., and were used as reference
animals in this study. All rats were maintained
under SPF conditions at 23 4- 2C, 55 4- 10%
relative humidity, a 12-h light-dark cycle, and
provided with a commercial pellet (CE-2, Clea
Japan Ltd., Tokyo, Japan) and water ad libitum
from an automatic sterilized water supply sys-
tem. All animals were handled in accordance
with the recommendations of the Animal Wel-
fare Committee of the Research Laboratories of
Torii Pharmaceutical Co., Ltd. The body weight
and plasma glucose levels were measured once
every 2 weeks from 6 to 20 weeks of age, and
thereafter, at 5-week intervals. The urine volume
was also determined.
Incidence of Diabetes and Survival Rate
Both in male (n =42) and female (n=39) SDT
rats, the urinary glucose and keto-body contentsA NEW DIABETIC NON-OBESE RAT MODEL 91
were determined using Multstix (R) (Bayer-San-
kyo Co., Tokyo, Japan), every week between 5
and 65 weeks of age, to determine the cumula-
tive incidence of DM and the survival rate. The
rats were diagnosed as being diabetic if the uri-
nary glucose was 3+ or higher.
Oral Glucose Tolerance Test (OGTT)
The OGTT was performed after 16 hr of fasting
in male SDT rats and male Crj CD(SD) rats at 12
weeks (n =6) and 16 weeks (n =6) of age, with
2 g/kg of glucose. Blood samples were collected
from the jugular vein before the administration
of glucose, and 30, 60 and 120 min after the oral
glucose administration. Plasma glucose levels
were measured by the glucose oxidase method
using Glucose-Test Wako(R) (Wako Pure Chemi-
cal Co., Osaka, Japan).
Biochemical Analysis
Male SDT rats and male Crj:CD(SD) rats
were placed in metabolic cages under a non-fast-
ing condition, and 18-hr urine samples were col-
lected. Blood samples were drawn from the
abdominal aorta of the animals under ether
anesthesia into tubes with the anticoagulant
dipotassium EDTA for hematological tests, and
heparin for plasma biochemical analysis. The
heparinized blood samples were centrifuged at
3,500rpm for 15 min, and the supernatant plas-
ma frozen at -80C until analysis. Hemoglobin
Alc (HbAlc) level in the blood was measured
using a HbAlc analyzer (DCA2000+, Bayer-
Sankyo Co.). Urinary protein concentration was
determined by the pyrogallol-red method (Micro
TP-Test Wako(R), Wako Pure Chemical Co.).
Plasma glucose (GLU), triglyceride (TG), total
cholesterol (T-CHO) and urea nitrogen (UN)
levels were measured with an automatic analy-
zer (Hitachi-7150, Hitachi Co., Tokyo, Japan).
Plasma level of immunoreactive insulin was
measured by enzyme-linked immunosorbent
assay (ELISA) using a rat insulin measurement
kit (Morinaga Institute of Biological Science,
Yokohama, Japan).
Histopathological Examinations
The pancreas in 10-, 12-, 14-, 16-, 18-,20-,25-,30-
,35-, 40-, 70- and 77-week-old rats were weighed
and fixed in 10% neutral buffered formalin. In
addition, their eyes were fixed in a mixture of
glutaraldehyde and formalin. The fixed speci-
mens were embedded in paraffin, sectioned at
4 tm, and stained with hematoxylin and eosin
(H&E) for histopathological examination.
Statistical Analysis
The data are given as mean+SD. The dif-
ferences between the SDT and age- and sex-
matched Crj" CD(SD) rats were compared by the
Student’s t-test. Probability values of P <
0.05 were considered as denoting significance.
RESULTS
Body Weight and Non-fasting Plasma
Glucose Levels
The changes in body weight of male and fe-
male SDT and Crj:CD(SD) rats are shown in
Figure 1. The average body weight of male
SDT rats was slightly lower than that of Crj CD
(SD) rats until 18 weeks of age, and then grad-
ually decreased as the incidence of diabetes in-
creased. A significant decrease in body weight
was observed from 20 weeks of age (Fig. 1A). On
the other hand, the average body weight of
female SDT rats from 6 to 40 weeks of age
increased gradually throughout the experimen-
tal period, and the changes in body weight in
female SDT rats were similar to those in female
Crj:CD(SD) rats (Fig. 1B). The changes in non-
fasting plasma glucose levels in male and female
SDT and Crj’CD(SD) rats are also shown in(Ip/tu) zsoonI etusId
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Figure 1. The non-fasting plasma glucose levels
in male SDT rats reached 701 4-103 mg/dl by 25
weeks of age (P < 0.01) and the values gradually
increased with advancing ages, whereas those in
Crj:CD(SD) rats were maintained at a steady
level (Fig. 1C). Plasma glucose levels in female
SDT rats were slightly but significantly higher
than those in female Crj:CD(SD) rats after 10
weeks of age (Fig. 1D).
than that noted in male SDT rats. In both
sexes of SDT rats after the onset of diabetes,
the symptoms of polyuria, polydipsia and
polyphagia were also observed. However, no
ketonuria was noted up to 65 weeks of age in
male and female SDT rats.
Biochemical Parameters
and Organ Weight
Incidence of Diabetes
The cumulative incidences of diabetes in male
and female SDT rats are shown in Figure 2. Glu-
cosuria appeared at 20-week-old in male SDT
rats (15/42). The time of onset of glucosuria was
coincident with that of plasma glucose elevation.
The cumulative incidence of diabetes increased
sharply to 52.4% in 25-week-old rats (22/42) and
100% in 40-week-old rats (42/42). Glucosuria
had not yet appeared even by 40-week-old
in female SDT rats. It was first observed at
45-week-old, and thereafter, the incidence of
diabetes gradually increased. However, the
maximal incidence of 33.3% noted in female
rats at 65 weeks of age was markedly lower
The changes in biochemical parameters and or-
gan weight in male SDT rats and male Crj:
CD(SD) rats are shown in Table I. The pancreas
weights of male SDT rats were significantly
lower (P < 0.01) than those in Crj CD(SD) rats at
25 weeks of age. Plasma levels of insulin in male
SDT rats gradually decreased from 10-week-old.
The plasma insulin levels of male SDT rats
were significantly lower (P <0.01) than those
in 25-week-old Crj:CD(SD) rats and marked
hyperglycemia (701 4-103mg/dl) in the non-
fasting state was associated with this hy-
poinsulinemia. Hypertriglyceridemia was also
noted in male 35-week-old SDT rats. Plasma
levels of triglyceride, in male SDT rats were 2.7
times higher (P < 0.01) than those in Crj CD(SD)
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FIGURE 2 Cumulative incidences of diabetes in SDT rats. ,, Male (n =42); o, Female (n =39).94 M. SHINOHARA et al.
TABLE Biochemical parameters and pancreas weight in male SDT and Crj’CD(SD) rats
SDT Crj" CD(SD)
Age in weeks 10 25 35 10 25 35
(No. of animals) (7) (7) (5) (6) (6) (6)
Pancreas weight (g) 1.2 + 0.1 1.1 4- 0.1"* 1.1 4- 0.1" 1.3 4- 0.1 1.4 4- 0.2
Plasma insulin (ng/ml) 2.8 4-1.2 1.2 4- 0.8"* 0.4 4- 0.2** 3.4 4-1.0 3.1 4-1.2
Plasma triglyceride (mg/dl) 64 4- 8** 146 4- 71 214 4- 54** 90 4-19 95 4- 35
Plasma total cholesterol (mg/dl) 57 4-5 724-15 87 4-24 564-7 624-11
Plasma urea nitrogen (mg/dl) 18.8 4- 3.0 26.7 4- 4.3 30.4 4- 3.0"* 23.6 4- 0.5 22.3 4- 3.6
UPE (mg/18 hr) 17.6 4-1.5 13.9 4- 7.4 62.1 4- 24.5** 20.2 4- 4.9 16.7 4- 6.6
HbAlc (%) 9.24-1.1"*
1.5 4- 0.3
3.2+ 1.3
78 + 20
614-6
21.1 4- 4.2
16.04-4.0
2.64-0.1
UPE: Urinary protein excretion. Each value represents the mean 4-SD.
*’**Significant difference from the age-matched Crj CD(SD) rat group values at P < 0.05, P < 0.01, respectively.
tAll rats in this group were observed with diabetes.
rats in this age group. Furthermore, the plasma
urea nitrogen levels, urinary protein excretion
and HbAlc levels in male SDT rats were 1.4,
3.9 and 3.5 times higher respectively (P <0.01)
than those in Crj CD(SD) rats at 35 weeks of age.
The plasma total cholesterol levels remained
unchanged in male SDT rats at 10, 25 and 35
weeks of age.
Survival Rate
The survival rates of male and female SDT rats
up to 65-week-old were 92.9% (39/42) and 97.4%
(38/39), respectively. The first death among male
and female SDT rats was observed at 40-week-
old and 45-week-old, respectively. In the mor-
tality of diabetic males (3/42), enlarged kidneys
were macroscopically observed, and dilation of
uriniferous tubules, accumulation of glycogen
in the epithelial cells of the uriniferous tubules,
interstital inflammatory cell infilitration, and
hyaline casts were histologically observed. Since
these changes were not observed in the mortal-
ity of females (1/39) without DM.
OGTT
The results of the OGTT in 12 and 16-week-
old male SDT rats and male Crj CD(SD) rats are
shown in Table II. Slight glucose intolerance was
first noted in SDT male rats when 12-week-old.
When 16-week-old, the fasting plasma glucose
levels in male SDT rats were similar to those in
Crj’CD(SD) rats. However, the plasma glucose
levels at 30, 60 and 120 min after glucose admin-
istration in male SDT rats (16w) were signifi-
cantly (P < 0.01) increased compared with those
in Crj:CD(SD) rats, indicating marked glucose
intolerance induced in male 16-week-old SDT
rats.
TABLE II Oral glucose tolerance test in male SDT and Crj’ CD(SD) rats at 12 and 16 weeks of age
Plasma glucose (mg/dl)
Age in No. of
weeks Strain animals 0 min 30 min 60min 120 min
Crj CD(SD) 6 130 4- 28 205 4- 24 184 4- 21
12
SDT 6 107 4-12 252 4- 39" 219 4- 43
Crj CD(SD) 6 123 4-14 178 +26 202 4- 8
16
SDT 6 116 4-14 266 4- 24** 317 4- 51"*
1284-18
150 4- 23
150 4-17
223 4- 63"
Each value represents the mean 4- SD.
*’**Significant difference from the age-matched Crj" CD(SD) rat group values at P < 0.05, P < 0.01, respectively.A NEW DIABETIC NON-OBESE RAT MODEL 95
Histopathological Findings
The histopathological features in the pancreas of
male SDT rats were as follows: in 10-20-week-
old, slight changes such as hemorrhage, hemo-
siderin deposition, inflammatory cell infiltration
and fibrosis in and around the islets; in 25-week-
old, hemosiderin deposition, cellular infiltra-
tion with lymphocytes and macrophages, and
fibrous tissue proliferation in and around the
pancreatic islets, dividing the islets into small
lobules (Fig. 3). By 30-40-weeks, hemosiderin
deposition and fibrosis were observed in and
around the islets. In addition, hyperplasia of
the small pancreatic ducts in and around the is-
lets was observed in 25-40-week-old animals.
The size and number of islets were further de-
creased. After 40-weeks, the islets were much
smaller, and partially replaced by connective
tissue. Both the number and size of the islets
were further decreased and eventually absent.
Macroscopic opacity of the lens was observed
at 40 weeks of age or older in diabetic male
SDT rats. Histopathologically, swelling, vacuo-
lation and disintegration of the lens fibers,
and formation of Morgani’s globules were
observed. In the retina, tractional retinal de-
tachment with fibrous proliferation in the
direction of the vitreous cavity, and thickening
and distortion of the retina were observed in
diabetic male SDT rats at 70 weeks of age (Figs.
4,5). However, marked retinal hemorrhage
was not observed in most case. In 77-week-old
male SDT rats, massive hemorrhaging in the
anterior chamber of the eye was observed in
FIGURE 3 Histopathological changes in the pancreas of a
male SDT rat at 25-week-old. Infiltration and fibrosis in and
around the pancreatic islets are seen (H&E stain, x 120). (See
Color Plate I).
FIGURE 4 Histopathological changes in the lens and retina
of a male SDT rat at 70-week-old. Swelling, vacuolation and
disintegration of the lens fibers, and fibrous proliferation in
the direction of the vitreous cavity are observed (H&E stain,
x 30). (See Color Plate II).96 M. SHINOHARA et al.
FIGURE 5 Histopathological changes in the retina of a male
SDT rat at 70-week-old. Tractional retinal detachment, thick-
ening and distortion are observed (H&E stain, x 73). (See
Color Plate III).
some cases (Fig. 6). This massive hemorrhage
was associated with fibrous proliferation
around the iris (Fig. 7A, B).
DISCUSSION
In the present study, glucosuria, polyuria and
polydipsia were observed in male SDT rats af-
ter 20 weeks of age and the nonfasting plasma
levels of insulin, glucose and triglyceride began
to change after 25 weeks. Clinical diabetes was
first confirmed in male SDT rats of this age. The
SDT strain of rats was separated from outbred
Crj:CD(SD) rats, and this strain was used as a
reference to the SDT strain. The body weight of
male SDT rats was significantly lower than
those of sex- and age-matched Crj" CD(SD) rats.
These data suggest that our .SDT rats should
be classified as non-obese diabetic animals. The
non-fasting plasma glucose level in male SDT
rats reached approximately 700mg/dl when
35-weeks. The non-fasting plasma insulin level
(0.4ng/ml) was significantly lower than that
in Crj:CD(SD) rats of the same age. Further-
more, hypertriglyceridemia was associated
with the hyperglycemia. Based on these data,
it is suggested that SDT rats belong to the
class of diabetic animal models with severe
hyperglycemia and hypoinsulinemia.
It was reported that insulin treatment was
required for the survival of spontaneously Type
1 diabetic rats such as BB, 51 LETL [7] and KDP 81
rats. However, SDT rats survived for a long time
even without insulin treatment. Ketonuria was
noted in BB rats [15] but not in SDT rats. It
was reported that the appearance of persistent
ketonuria associated with hyperglycemia or se-
vere glucosuria in a diabetic patient points to an
unacceptably severe level of metabolic distur-
bance and indicates an urgent need for correc-
tive action. [16] From these data, it is suggested
that glucose and lipid metabolism might be dif-
ferently disturbed in SDT and BB rats. s,171 In
SDT rats, the cumulative incidence of diabetes
was shown to be 100% in male rats by 40-week-
old and only 33.3% in female rats even by 65-
week-old. Sex difference was similarly observed
in Wistar Fatty and OLETF rats. [13,14]
To clarify the type of DM in the SDT rat, mor-
phological examination of the pancreas was
carried out. Histopathological examination re-
vealed hemorrhage in and around the islets
by about 10-week-old followed by inflammatory
cell infiltration and fibrosis around the islets,
resulting in a significantly decreased number
and size of the islets in 40-week-old animals.
Although these time-dependent histopatho-
logical changes, in particular, the morpholo.gical
pattern of fibrosis around the islets, resembled
those observed in WBN/Kob rats,
[18-20] inflam-
mation of the exocrine pancreas was consider-
ed to be less prominent than that in WBN/Kob
rats. 18-201 The Type 1 diabetic BB rat was char-
acterized by prominent insulitis and lympho-
penia, namely deficiency of T lymphocytes,
[21]FIGURE 6 Massive hemorrhage in the anterior chamber observed in a male SDT rat at 77-week-old macroscopically. The
massive hemorrhage was observed in the left eye (L) but not in the right eye (R). (See Color Plate IV).
FIGURE 7 Histopathological changes in the iris of a male SDT rat in Figure 6. A: massive hemorrhage (H) associated with
fibrous proliferation over the iris (I). B: higher magnification of the portion of massive hemorrhage in Figure 7A. AC: anterior
chamber. A (H&E stain, x 100); B (H&E stain, x 475). (See Color Plate V).98 M. SHINOHARA et al.
FIGURE 7 (Continued). (See Color Plate V).
however, such insulitis and lymphopenia were formation of Morgani’s globules were observed.
not observed in the SDT rat. The histological These abnormalities were also observed in the
findings and clinical features suggest that the aged WBN/Kob rats,
[26] however, SDT rats
SDT rat should be classified as a Type 2 DM showed these changes at an earlier age. Among
model. Recently, new diabetic mouse models the various ocular complications in diabetes, the
such as Akita mice [22] and TSOD mice
[23] have most serious is retinopathy. Since it produces
been reported. However, new spontaneously more blindness that any other ocular involve-
diabetic models have not been reported in rats. ment of diabetes. According to the classification
Therefore, it is interest that the SDT rat, of Davis et al., human diabetic retinopathy is
established by us, has a disease resembling mainly classified into nonproliferative or pro-
human non-obese severe Type 2 diabetes with liferative retinopathy.
[27] It was reported that
insulin hyposecretion, morphological changes like human diabetic
Various complications of diabetes have al- retinopathy were induced in some animal
ready been reported in spontaneously diabetic mo.dels. For example, the spontaneously diabetic
animal models. As for ocular lesions, cataract BB rats, 28J galactosemic dogs,
[29] storeptozoto-
was observed in WBN/Kob rats at 15-24 cin-diabeticrats
30j and oxygen-induced retino-
months.
[24] Cataract is one of the ocular com- pathic mice [31] are well known. However, there
plications observed in diabetic patients. I25 In are no other reports of lesions resembling
the present study, in diabetic male SDT rats, human proliferative retinopathy than oxygen-
macroscopic opacity of the lens with histo- induced retinopathic models, so useful sponta-
pathological changes such as swelling, vacuola- neously proliferative retinopathic models must
tion and disintegration of the lens fibers, and be developed. Morphologically, diabetic maleA NEW DIABETIC NON-OBESE RAT MODEL 99
SDT rats showed tractional retinal detachment
with fibrous proliferation, thickening and dis-
tortion of the retina by 70 weeks of age. These
changes resemble those seen in human prolif-
erative retinopathy. Since these changes were
not observed in age-matched Crj CD(SD) rats or
age-matched female SDT rats without DM, it is
suggested that the ocular lesions in SDT rats
might be caused by diabetic condition espe-
cially chronic hyperglycemic stress. However,
no significant retinal hemorrhage was observed
in most cases. The fibrous proliferation did not
show significant neovascular formation. On the
other hand, massive hemorrhage in the anteri-
or chamber of the eye was observed in diabetic
males. The massive hemorrhage associated with
fibrous proliferation around the iris was ob-
served histopathologically. These findings cor-
respond to the hemorrhage that resulted from
iris neovascularization, which is frequently com-
plicated with severe untreated proliferative dia-
betic retinopathy. Although a low incidence of
retinal hemorrhage and poor development of
neovascular formation in the proliferative tissue
over the retina did not match the typical hu-
man proliferative diabetic retinopathy, other ocu-
lar changes observed in SDT rats, i.e., cataract,
proliferative changes of the vitreous and the
retina, and massive hemorrhage in the anterior
chamber, resemble those seen in human pro-
liferative diabetic retinopathy. However, in
this study, only conventional histopathologic
standing with hematoxylin-eosin was done to
evaluate the ocular changes. To obtain a better
understanding of retinopathy in the SDT rat,
analysis of the retinal vasculature using a tryp-
sin digest technique and fluorescein-dextran
angiography are required.
Development of a new diabetic model which
can exhibit the complication of diabetic retino-
pathy resembling that in humans would be rath-
er useful to clarify the cause of human diabetic
retinopathy and to develop treatment methods.
Our research has also paved the way for
new approaches in human diabetic retinopathy
research. If factors predictive of potential dia-
betic retinopathy can be found in SDT rats, these
findings can be utilized to advantage in hu-
mans. We believe that the SDT rat is a highly
useful model for strengthening our understand-
ing of the disease process of diabetic complica-
tions in humans.
As described above, we have established this
diabetic strain and clarify its diabetic character-
istics. However, our colony of SDT rats is still
too small to make the rats available to diabetes
researchers. Our much effort will be required to
make the colony big enough.
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